Literature DB >> 32028121

Synthetic route sourcing of illicit at home cannabidiol (CBD) isomerization to psychoactive cannabinoids using ion mobility-coupled-LC-MS/MS.

Thomas D Kiselak1, Rachel Koerber2, Guido F Verbeck3.   

Abstract

This study focuses on the chemical route sourcing of illicitly produced Δ9-Tetrahydrocannabinol (Δ9-THC) via the acid-catalyzed cannabidiol isomerization reaction. Each of the acid-catalyzed reactions used acids that are readily available for the general population such as battery acid, muriatic acid, and vinegar. After the acid-catalyzed isomerization was complete, an analysis using Liquid Chromatography-coupled-Mass Spectrometry (LC-MS)-coupled-ion mobility to confirm all synthetic impurities in the sample was conducted. The conducted chemical route sourcing allows law enforcement to be able to determine how CBD was converted to psychoactive cannabinoids. Specifically, 10-methoxy-THC, 11-hydroxy-THC, 11,5″-dihydroxy-Δ9-THC, and 5″-hydroxy-CBD were able to be used as indicators in the determination of the chemical route sourcing. Additionally, the ion mobility allowed for a rapid secondary separation of the psychoactive cannabinoids without the need for the long LC/MS analysis time.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Cannabidiol; Ion mobility; Liquid chromatography; Psychoactive cannabinoids; Synthetic route

Mesh:

Substances:

Year:  2020        PMID: 32028121     DOI: 10.1016/j.forsciint.2020.110173

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  2 in total

1.  Novel Δ8-Tetrahydrocannabinol Vaporizers Contain Unlabeled Adulterants, Unintended Byproducts of Chemical Synthesis, and Heavy Metals.

Authors:  Jiries Meehan-Atrash; Irfan Rahman
Journal:  Chem Res Toxicol       Date:  2021-12-10       Impact factor: 3.739

2.  Cannabis Vaping: Existing and Emerging Modalities, Chemistry, and Pulmonary Toxicology.

Authors:  Jiries Meehan-Atrash; Irfan Rahman
Journal:  Chem Res Toxicol       Date:  2021-10-08       Impact factor: 3.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.